Canada markets closed

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.03-0.14 (-2.27%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close6.17
Open6.17
Bid5.75 x 1100
Ask6.06 x 1000
Day's Range5.93 - 6.43
52 Week Range3.60 - 9.96
Volume73,946
Avg. Volume86,024
Market Cap153.439M
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-1.25
Earnings DateAug 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est21.00
  • Motley Fool

    TFF Pharmaceuticals, Inc. (TFFP) Q2 2022 Earnings Call Transcript

    With me on the line today is Glenn Mattes, president and CEO of TFF; Kirk Coleman, chief financial officer; Dr. Dale Christensen, TFF's director of clinical development; Dr. The press release announcing our second quarter results is available on the TFF Pharmaceuticals website.

  • GlobeNewswire

    TFF Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

    Phase 2 Inhaled Voriconazole Powder and Inhaled Tacrolimus Powder Programs Continue to Advance Expands R&D Operations with New Austin, TX Facility Recent Feasibility Work Confirms Utility of Thin Film Freezing in Developing Next- Generation Vaccines Conference Call and Webcast Scheduled Today, Thursday, August 11, 2022, at 4:30 PM ET FORT WORTH, Texas, Aug. 11, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and

  • GlobeNewswire

    TFF Pharmaceuticals to Hold Second Quarter 2022 Financial and Business Results Conference Call on August 11, 2022

    Company conference call and webcast at 4:30 PM ETFORT WORTH, Texas, Aug. 02, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that it will release its financial results and business update for the second quarter of 2022 on Thursday, August 11, 2022, at the close of the U.S. financial mar